-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Neurogene, Maintains $65 Price Target

Benzinga·10/28/2026 11:37:08
Listen to the news
HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Neurogene (NASDAQ:NGNE) with a Buy and maintains $65 price target.